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Methylobacterium and Its Role in Health Care-Associated Infection
Julia Kovaleva,a John E. Degener,a Henny C. van der Meib
Department of Medical Microbiology and Infection Control, University of Groningen, University Medical Center Groningen, Groningen, The Netherlandsa; Department of
Biomedical Engineering, University of Groningen, University Medical Center Groningen, Groningen, The Netherlandsb
Methylobacterium species are a cause of health care-associated infection, including infections in immunocompromised hosts.
The ability ofMethylobacterium species to form biofilms and to develop resistance to high temperatures, drying, and disinfect-
ing agents may explain the colonization ofMethylobacterium in the hospital environment in, e.g., endoscopes. Due to its slow
growth, it can be easily missed during microbiological surveillance of endoscope reprocessing. The purpose of this minireview is
to present an overview of documented infections and cross-contaminations withMethylobacterium related to endoscopic proce-
dures and to illustrate the health care-associated relevance of this slow-growing bacterium.
Methylobacterium species are fastidious, Gram-negative bacilliwhich have been reported to be opportunistic pathogens in
immunocompromised patients. These species form pink-pig-
mented colonies on agar plates and have been frequently isolated
from tap water in hospitals. The ability to form biofilms and to
develop tolerance to disinfecting agents, high temperatures, and
drying may explain the frequent occurrence and colonization of
Methylobacterium in the hospital environment. Here we review
the microbiology and health care-associated relevance of this
slow-growing bacterium with particular attention to biofilm for-
mation in medical devices and transmission of Methylobacterium
during endoscopic procedures.
MICROBIOLOGY, LABORATORY IDENTIFICATION, AND
ANTIBIOTIC SUSCEPTIBILITY
The genus Methylobacterium, of the family Methylobacteriaceae
(class Alphaproteobacteria), was described as a new genus of fac-
ultative methylotrophic bacteria by Patt et al. in 1976 (1). This
genus, including the first Methylobacterium organophilum and 3
species from the Pseudomonas genus (e.g., Pseudomonas mesoph-
ilica, Pseudomonas radiora, and Pseudomonas rhodos), currently
consists of 49 different species (http://www.bacterio.net/methylo
bacterium.html; last accessed 20 December 2013). Methylobacte-
rium spp. are commonly isolated from various natural environ-
ments (i.e., leaf surfaces, soil, dust, and fresh water) (2, 3).
Methylobacterium spp. are strictly aerobic, facultativelymethy-
lotrophic, fastidious, slow-growing bacteria. They form small (1
to 2mm in diameter), pink-pigmented colonies on ordinary solid
media such as tripticase soy agar, sheep blood agar, nutrient agar,
and Mueller-Hinton agar and on plate count agar and R2A agar,
two media used for plate count analysis in drinking water (4).
Optimum growth occurs between 25 and 30°C after 5 to 7 days of
incubation, with moderate growth at 35°C and no growth at 42°C
(4–6). The best growth was observed on Sabouraud dextrose agar
and buffered charcoal yeast extract agar. The species grow as
Gram-negative or gram-variable, pleomorphic, non-spore-form-
ing, vacuolated, rod-shaped cells and have one polar flagellum (2).
Methylobacterium spp. are nonfermenting, -galactosidase- and
nitrate reductase-negative, and trypsin- and urease-positive bac-
teria and are resistant to desferrioxamine (7). These biochemical
tests are helpful to differentiate methylobacteria from other aero-
bically growing Gram-negative bacteria which form pink-pig-
mented colonies on blood agar (i.e., Serratia, Azospirillum, Ro-
seomonas, and Asaia).Methylobacterium spp. were reported to be
catalase and oxidase positive (1) but were oxidase negative in tests
with the dimethyl-paraphenylenediamine reagent (2).
Identification of Methylobacterium is performed using com-
mercially available manual-identification test strips (8, 9). How-
ever, determination to the species level by these systems can be
difficult. 16S rRNA gene sequence analysis can differentiate
Methylobacterium isolates to the species level with pairwise simi-
larity of 16S rRNA gene sequences of between 97% and 99.6% (10,
11). Recent developments in mass spectrometry (MS) have shed
light on rapid and precise identification ofMethylobacterium spp.
Tani et al. (10) applied thewhole-cellmatrix-assisted laser desorp-
tion ionization–time of flight (MALDI) mass spectrometry (WC-
MS) technique to identify Methylobacterium spp. collected from
plant samples. A total of 213Methylobacterium isolates were ana-
lyzed with WC-MS using MALDI Biotyper software (Bruker Dal-
tonics), and this identification was confirmed by 16S rRNA gene
sequencing. The WC-MS technique demonstrated high effective-
ness in the identification of known and novel species of Methylo-
bacterium.
Methylobacterium spp. are susceptible to amikacin, gentami-
cin, ciprofloxacin, and trimethoprim-sulfamethoxazole and have
various levels of susceptibility to the -lactam antibiotics (due to
-lactamase production), with high sensitivity to ceftriaxone,
ceftizoxime, and imipenem (6, 8, 12). Discordant carbapenem
susceptibilities, with high sensitivity to imipenem (MIC 0.25 to
1 mg/liter) and resistance to meropenem (MIC  32 mg/liter),
seem to be a distinctive feature of Methylobacterium spp. (13).
HEALTH CARE-ASSOCIATED TRANSMISSION OF
METHYLOBACTERIUM
Members of the genusMethylobacterium are major inhabitants of
aqueous environments, including potable water supplies and hos-
pital tap water (4). Transmission of Methylobacterium spp. in the
hospital environment has been related to contaminated tap water.
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These species have also been isolated from water in dental and
blood bank purification units (14, 15) and from endoscopes and
automated endoscope reprocessors (AERs), which are probably
contaminated by the use of nonsterile water for rinsing (16–18).
High resistance to dehydration, chlorination, and elevated tem-
peratures and slow growth and the ability to form biofilms can
explain the frequent occurrence and colonization of Methylobac-
terium in the hospital environment (12, 18, 19). Since methylo-
bacteria have been isolated from tap water in hospital units, Hor-
nei et al. (5) suggested monitoring water for the occurrence of
methylobacteria in hospital units in which immunocompromised
patients are admitted.
Despite low virulence, Methylobacterium is able to cause colo-
nization and infections in immunocompromised patients (3, 8).
Methylobacterium mesophilicum,Methylobacterium zatmanii, and
Methylobacterium extorquens are the three most commonly re-
ported species isolated fromnormally sterile body sites, i.e., blood,
liquor cerebrospinalis, bone marrow, synovia, and ascitic and
peritoneal fluids (3, 5). An underlying state of immunosuppres-
sion, including that corresponding to solid or hematologic malig-
nancy, organ transplant, renal failure,HIV infection, tuberculosis,
or alcoholism, may predispose subjects to a systemic infection
caused by methylobacteria (3, 8). In general, Methylobacterium
spp. cause mild clinical symptoms, such as fever, but severe infec-
tions, including bloodstream infections, peritonitis, and pneumo-
nia, have also been reported (3, 8). Central catheter infections are
the most common portal of infection in these situations.
Most reportedMethylobacterium infections have been nosoco-
mial. Two cases of bloodstream infections due to M. mesophilica
were attributed to tap water used for oral irrigation for patients
with mucositis as a complication after bone marrow transplanta-
tion (20). Contaminated preservative fluid used for bone marrow
harvesting was a possible source of Methylobacterium bacteremia
in a patient receiving hematopoietic stem cell transplantation
(21). A patient receiving continuous ambulatory peritoneal dial-
ysis developed recurrent peritonitis due to M. mesophilicum,
which was also isolated from contaminated stagnant water in the
bathroom (22). Several Methylobacterium infections in immuno-
compromised patients have been associated with environmental
exposure (ingestion of raw vegetables, gardening, swimming in a
river, and exposure to soil, leaves, and flowers) (3) just before
development of infection.
ENDOSCOPE REPROCESSING AND METHYLOBACTERIUM
TRANSMISSION RELATED TO ENDOSCOPIC PROCEDURES
Contaminated endoscopes are medical devices frequently associ-
ated with outbreaks of health care-associated infections (19, 23).
These instruments are difficult to disinfect and easy to damage
because of their complex design with multiple internal channels
and narrow lumina.Most flexible endoscopes belong to semicriti-
cal devices which come into contact with mucous membranes
during use and may be either sterilized or disinfected. Flexible
endoscopes for therapeutic procedures (i.e., bronchoscopy and
gastrointestinal endoscopic procedures) used in sterile body cav-
ities are classified as critical devices and require sterilization after
each procedure. Due to their material composition, most flexible
endoscopes cannot be steam sterilized but tolerate ethylene oxide
and hydrogen peroxide plasma sterilization.
Accurate reprocessing of flexible endoscopes involves cleaning
and high-level disinfection followed by rinsing with bacterium-
free water and drying before storage (19). Glutaraldehyde and
peracetic acid are disinfecting agents frequently used for decon-
tamination of flexible endoscopes. They are active against viruses,
fungi, mycobacteria, and all vegetative bacteria, includingMethy-
lobacterium. However, resistance of M. mesophilicum to 2% glu-
taraldehyde has been reported (24). A recent study demonstrated
high efficacy of 1% peracetic acid against M. extorquens in the
planktonic state, but the disinfectant was less efficient in biofilms
(18).
According to Furuhata and Koike (25), 70% (70/100) of exam-
ined samples from chlorinated drinking water were positive for
Methylobacterium spp. and 25% to 93% of methylobacterial
strains isolated from tap water were highly resistant to chlorine
and survived contact at 0.1 mg/liter concentration of free residual
chlorine for 5 min (11, 25).
Accurate endoscope drying is crucial, whereas a humid envi-
ronment facilitates microbial growth during storage (19). The
final drying steps greatly reduce the risk posed by remaining
pathogens, as well as the possibility of recontamination of the
endoscope by waterborne microorganisms such as Pseudomonas
spp., Acinetobacter spp., and Methylobacterium spp. (19, 23).
Members of the genusMethylobacterium have been reported to be
highly resistant to dehydration and high temperatures (18).
Hence, they can survive in endoscope channels during inadequate
or insufficient drying, resulting in recontamination of endo-
scopes.
Methylobacterium outbreaks after endoscopic procedures have
been related to contaminated tap water (6, 24), AERs containing
biofilm (16), and contaminated endoscope channels (17, 18).
Cross-contaminations with Methylobacterium in 7 patients
during bronchoscopy have, despite the usual disinfection proce-
dure, been related to contamination by tap water of endoscope
channels (6). Growth of pink-pigmented bacteria, later identified
asM.mesophilicum, was observed inmycological surveillance cul-
tures of samples obtained from a bronchoscope which was used
for a diagnostic procedure in a patient with an atypical pneumo-
nia. Growth ofMethylobacteriumwas discovered as a consequence
of the extended incubation time for fungal culture. In the next 3
months,M. mesophilicum was isolated from 6 other patients after
bronchoscopy. Cultures obtained from bronchoscopes, biopsy
forceps, AERs, tubing, glutaraldehyde disinfectant, and environ-
mental samples from the bronchoscopy unit were negative for this
bacterium.M.mesophilicumwas isolated from tap water collected
from the sink faucet in the bronchoscopy room. It was considered
a colonizer because none of the patients developed a postbroncho-
scopy infection from this organism.
Cross-contaminations with bronchoscopy-associated Methy-
lobacterium in 18 patients have been documented by Kressel and
Kidd (16). M. mesophilicum and Mycobacterium chelonae were
isolated from deep respiratory specimens obtained from venti-
lated patients during bronchoscopy. None of the patients mani-
fested postendoscopic infection with this bacterium.M. mesophi-
licum grew in the cultures obtained from AERs and from 2%
glutaraldehyde used during the automated disinfection procedure
and did not grow from bronchoscopes, tap water, or unopened
glutaraldehyde containers or from the containers used for collect-
ing the clinical samples. The presence ofM. mesophilicum biofilm
on the tubing fromone of theAERswas confirmed.Contaminated
endoscope disinfectors were replaced by new AERs that use per-
acetic acid instead of glutaraldehyde for disinfection procedures.
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NosocomialM.mesophilicum transmission was related to con-
taminated 2% glutaraldehyde solution used to manually disinfect
the bronchoscopes (24). Environmental cultures from the AER,
bronchoscopes, gastroscopes, and brushes were positive for this
pink-pigment-forming bacterium. The procedure of reprocessing
endoscopes was investigated and showed no shortcomings in
technique. Endoscopes were sent for ethylene oxide sterilization,
but M. mesophilicum from endoscope channels was identified
again 2 months later. The water supply was assumed to be the
source of contamination, and a submicron filter was installed to
get filtered tap water for rinsing of endoscopes after cleaning and
disinfection procedures. After disinfection and sterilization of the
reprocessing equipment, subsequent cultures were negative for 4
months. M. mesophilicum caused no infections in patients after
endoscopic procedures with contaminated bronchoscopes.
Repeated contaminations of flexible bronchoscopes with
Methylobacterium spp. have been detected at the University Med-
ical Center Groningen (UMCG), Groningen, The Netherlands
(18). Growth of the bacterium, later identified as M. extorquens,
was accidentally observed on Sabouraud dextrose agar used for
culturing of surveillance samples from endoscopes. Because of the
slow growth and unclear significance of this bacterium, it was
necessary to prolong the incubation time for 7 days to recover
these bacteria from the surveillance samples. Cultures were posi-
tive for Methylobacterium from 2009 to 2011 from endoscope
channels, particularly from bronchoscopes. Methylobacterium
was also isolated from bronchoalveolar lavage fluid samples from
the patients after bronchoscopy. We considered Methylobacte-
rium to be a contaminating nonpathogen causing the coloniza-
tion, because no patient manifested true infection with this bac-
terium. The procedures of endoscope reprocessing revealed no
recurrence. Environmental cultures from the endoscopy unit, in-
cluding AERs and rinsing water, were negative for Methylobacte-
rium. Biofilm formation inside bronchoscope channels was sus-
pected. Strains of M. extorquens isolated from the contaminated
flexible bronchoscope were investigated for the ability to form
biofilms, and the effects of peracetic acid disinfection and drying
on M. extorquens biofilm formation were studied (see the section
discussing the impact of biofilm formation by Methylobacterium
below).
To date, only one case of Methylobacterium bacteremia in a
patient following endoscopy has been published (17). A 77-year-
old patient with biliary lithiasis underwent a biliary sphincterot-
omy and implantation of a prosthesis in the biliary tract via endo-
scopic retrograde cholangiopancreatography. The prosthesis was
removed by means of an endoscopic procedure 10 days later. The
next day, the patient developed fever, and after 5 days, bacterial
growth was detected in one aerobic blood culture bottle.M.meso-
philicum was isolated from a positive blood culture, and the de-
termination was confirmed by 16S rRNA gene sequencing. The
procedures of peracetic-acid-based decontamination and endo-
scope washer maintenance appeared to be effective because no
recurrence ofMethylobacteriumwas seen.Water samples obtained
for culture from the tap water points in the endoscopy room and
from the AER, before and after rinsing, were negative. The inner
endoscope channels were found to be the source of contamination
with M. mesophilicum. The endoscope was sent to the manufac-
turer for replacement of the inner channel sheath.
IMPACT OF BIOFILM FORMATION BY METHYLOBACTERIUM
A biofilm is an assemblage of microbial cells that is attached to a
surface and enclosed in a matrix of exopolymeric substances (26).
Biofilms may form on different surfaces, including medical de-
vices, water supply systems, or endoscope channels (16, 18, 26).
They are extremely difficult to remove and allowmicroorganisms
to survive under conditions of drying and chemical and antibiotic
exposure. Settlement of biofilm-producing species inside endo-
scope channels can result in failure of the endoscope reprocessing
and is an important factor in the pathogenesis of endoscopy-re-
lated infections (19, 23). The reduced sensitivity of bacteria to
disinfectants within a biofilm can be explained by poor penetra-
tion of a disinfectant into the underlying cells, chemical interac-
tion between the biofilm itself and the disinfectant, and the low
growth rate and nutrient limitation ofmicroorganisms in biofilms
(27).
The presence of biofilm on the tubing from one of the AERs
with growth of M. mesophilicum was the source of an outbreak
described in patients following bronchoscopy (16). Also, biofilm
formation inside endoscope channels was suspected to be the
cause of repeated cross-contaminations of flexible bronchoscopes
withM. extorquens at the UMCG (18). Mimicking biofilm forma-
tion in an in vitro study, M. extorquens isolated from a contami-
nated bronchoscope was tested in 96-well microtiter plates (18).
In this model, the effects of the 1% peracetic acid disinfectant (10
min incubation at 25°C)without andwith the additional drying (2
h at 50°C followed by 7 days drying at room temperature) on M.
extorquens biofilm formation were studied to imitate the proce-
dures used for reprocessing of flexible endoscopes.
M. extorquens had a strong biofilm-producing ability, with the
highest biofilm amount and themaximummetabolic activity after
7 days incubation in R2A broth (18). The use of 1% peracetic acid
disinfectant caused a marked inhibition of M. extorquens growth
in 2-, 5-, and 7-day biofilms directly after treatment. Regrowth of
M. extorquens biofilms occurred following 7 days of incubation
with R2A broth directly after the disinfection procedure. Re-
growth of M. extorquens biofilms was observed in wells after dis-
infection when the drying procedure was skipped. No biofilm
regrowth was observed after a drying procedure. This study dem-
onstrated insufficient efficacy of the peracetic acid against M. ex-
torquens biofilms and high efficacy of the drying procedure after
the disinfection step against Methylobacterium in biofilms.
According to the literature,Methylobacterium has a strong bio-
film-producing ability (28–30). Simões et al. (29) tested the effects
of sodium hypochlorite (liquid bleach) on the activity and cultur-
ability of Methylobacterium biofilms. Methylobacterium biofilms
recovered their mass, activity, and culturability after 1 h of treat-
ment with 0.01% sodium hypochlorite; a concentration of only
0.1% completely inactivated this bacterium in biofilms after 1 h of
incubation. Methylobacterium in biofilms survived after contact
with other cleaning agents, including 1% benzalkonium chloride
for 24 h (28). The strains demonstrated a high tolerance to drying.
Ten days after drying, the reduction in the survival ofMethylobac-
terium was less than 1 log. Some strains of Methylobacterium in
biofilms survived and exhibited a potential to grow after 4 weeks
of desiccation without any nutrients.
CONCLUSION
Methylobacterium spp. are fastidious microorganisms that have
been described as a cause of cross-contaminations related to en-
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doscopes and reprocessing equipment and have been reported as a
cause of infections in immunocompromised patients. Due to its
slow growth, the bacterium can be easily missed during surveil-
lance of endoscope reprocessing. The ability to form biofilms and
to exhibit tolerance to cleaning and disinfecting agents and to high
temperatures and drying is probably the cause of their predomi-
nance in the hospital environment, particularly in tap water and
endoscope channels.
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